ConductScience.org, home

Paper41774209

Computer-aided drug design in acute myeloid leukemia: a comprehensive review of advances, challenges, and future prospect.

Hao L and 7 others. J Comput Aided Mol Des, 2026. Cited by 0 papers, by iCite.

Cite this record

ConductScience Library. Computer-aided drug design in acute myeloid leukemia: a comprehensive review of advances, challenges, and future prospect. Papers, record 41774209. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41774209

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Computer-aided drug design in acute myeloid leukemia: a comprehensive review of advances, challenges, and future prospect.
PubMed
Journal
J Comput Aided Mol Des
PubMed
Year
2026
PubMed
Publication types
Journal Article, Review, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
0
iCite
Revised in PubMed
2026-11-03
PubMed

Authors8

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Hao LLu
2Wang JJiaxin
3Chen TTangting
4Tu SShichan
5Liu XXiaoyue
6Du XXi
7Wu JJianming
8Wang YYiwei

Source PubMed

Download CSV of authors

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Leukemia, Myeloid, AcuteMajor topic
Computer-Aided DesignMajor topic
Drug DesignMajor topic
Antineoplastic AgentsMajor topic
Humans
Molecular Docking Simulation
Molecular Dynamics Simulation
Artificial Intelligence
fms-Like Tyrosine Kinase 3
Ligands
Protein Kinase Inhibitors
Drug Discovery

Source PubMed

Download CSV of topics

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
2025NSFSC2167Sichuan Science and Technology Program of ChinaPubMed

Source PubMed

Download CSV of grants

References120

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
133902106Small-molecule inhibition of METTL3 as a strategy against myeloid leukaemia.Nature2021https://conductscience.org/library/papers/33902106PubMed
222409994Drug resistance: still a daunting challenge to the successful treatment of AML.Drug Resist Updat2012https://conductscience.org/library/papers/22409994PubMed
339726698A hitchhiker's guide to deep chemical language processing for bioactivity prediction.Digit Discov2025https://conductscience.org/library/papers/39726698PubMed
427391254Molecular Dynamics Simulations and Kinetic Measurements to Estimate and Predict Protein-Ligand Residence Times.J Med Chem2016https://conductscience.org/library/papers/27391254PubMed
526077712Accurately modeling nanosecond protein dynamics requires at least microseconds of simulation.J Comput Chem2016https://conductscience.org/library/papers/26077712PubMed
630651634Targeting FLT3 mutations in AML: review of current knowledge and evidence.Leukemia2019https://conductscience.org/library/papers/30651634PubMed
739300079Current status and research directions in acute myeloid leukemia.Blood Cancer J2024https://conductscience.org/library/papers/39300079PubMed
837838760The maximal and current accuracy of rigorous protein-ligand binding free energy calculations.Commun Chem2023https://conductscience.org/library/papers/37838760PubMed
930651561Clinical resistance to crenolanib in acute myeloid leukemia due to diverse molecular mechanisms.Nat Commun2019https://conductscience.org/library/papers/30651561PubMed
1026205061Molecular docking and structure-based drug design strategies.Molecules2015https://conductscience.org/library/papers/26205061PubMed
1136237321Targeted therapy in NPM1-mutated AML: Knowns and unknowns.Front Oncol2022https://conductscience.org/library/papers/36237321PubMed
1234790902Discovery of a first-in-class reversible DNMT1-selective inhibitor with improved tolerability and efficacy in acute myeloid leukemia.Nat Cancer2021https://conductscience.org/library/papers/34790902PubMed
1325837374Crystal structure of the FLT3 kinase domain bound to the inhibitor Quizartinib (AC220).PLoS One2015https://conductscience.org/library/papers/25837374PubMed
149389713CGP 57148, a tyrosine kinase inhibitor, inhibits the growth of cells expressing BCR-ABL, TEL-ABL, and TEL-PDGFR fusion proteins.Blood1997https://conductscience.org/library/papers/9389713PubMed
1538913862ADMET-AI: a machine learning ADMET platform for evaluation of large-scale chemical libraries.Bioinformatics2024https://conductscience.org/library/papers/38913862PubMed
1623291630ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets.Nat Med2013https://conductscience.org/library/papers/23291630PubMed
1739078434Significance of targeting DNMT3A mutations in AML.Ann Hematol2025https://conductscience.org/library/papers/39078434PubMed
1829186125Promoter-bound METTL3 maintains myeloid leukaemia by m6A-dependent translation control.Nature2017https://conductscience.org/library/papers/29186125PubMed
1929139324Molecular dynamics simulations and novel drug discovery.Expert Opin Drug Discov2018https://conductscience.org/library/papers/29139324PubMed
2027326911Descriptors and their selection methods in QSAR analysis: paradigm for drug design.Drug Discov Today2016https://conductscience.org/library/papers/27326911PubMed

See all 120 referencesDownload CSV of references

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Cited by
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41774209

GET https://conductscience.org/api/papers/v1/41774209/references?page=2